Financial intelligence for Asia's healthcare markets
 
 
Remember me:


News articles    

Shanghai-based biotech firm Lepu Biotech has completed a ¥1.291 billion ($186 million) Series B funding round by Riverhead Capital, Sunshine Insurance Group and Ping An Capital.
ABM Therapeutics, has raised $20 million in a Series A+ funding round led by China Growth Capital.
Jabrehoo, a Chinese integrated reproductive and genetic service company, has raised ¥100 million ($14.35 million) in a series B+ funding round led by Apricot Capital.
Global Health has announced an agreement with New South Wales Department of Communities and Justice to implement the company’s MasterCare Client Management System for the Elver Trauma Treatment Program.
Beijing-based Sherpa Healthcare Partners today announced the final closing of the oversubscribed Sherpa Healthcare Fund I, L.P.
Ping An Insurance (Group) Company of China has signed an agreement with Shionogi (Hong Kong) Company, a subsidiary of Shionogi & Co to launch joint ventures in Shanghai and Hong Kong.
Singapore-based Docquity, Southeast Asia's largest professional network of doctors, has partnered with Novartis to deliver bite-sized, continual learning, and education support to doctors across seven countries in Asia.
ASLAN Pharmaceuticals a clinical-stage immunology and oncology focused biopharmaceutical company is preparing a primary listing on the Nasdaq Global Market and will delist from the Taipei Exchange.
CGBIO, a healthcare company which has developed an aesthetic premium filler has signed a Memorandum of Understanding with DNCompany, which has distribution and sales capabilities in the aesthetics market in South Korea.
Healthcare business B. Braun Indonesia has donated 170,000 masks to support health workers during the Covid-19 pandemic distributed to more than 30 hospitals specialised in Covid-19 throughout Indonesia.
12345678910...

Subscribe to our news RSS feed Get the RSS for HealthInvestor Asia



Civica

AON


Markets

The IPO market in Hong Kong is hotting up again and it looks as though 2019 is going to be as busy with biotech company floats as last year was.


Podcasts

Analysis

HealthInvestor Asia twitter feed



Podcasts

HealthInvestor UK